The role of immunotherapy in relapse/refractory precursor-B acute lymphoblastic leukaemia: real-life UK/Ireland experience in children and young adults. (2021)
Attributed to:
Phase 1 evaluation of CRISPR-CAR gene edited T cells in relapsed refractory B cell acute lymphoblastic leukaemia
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bjh.17198
PubMed Identifier: 33216967
Publication URI: http://europepmc.org/abstract/MED/33216967
Type: Journal Article/Review
Volume: 192
Parent Publication: British journal of haematology
Issue: 2
ISSN: 0007-1048